ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 055,36
0,40%
DAX
17 896,50
-0,14%
Brent Oil
83,54
0,00%
Bitcoin
58 966,03
1,25%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Adial Pharmaceuticals Inc (ADIL)

  7. Adial Pharmaceuticals Inc (ADIL) Actualités

ADIL Adial Pharmaceuticals Inc

1,80
0,04 (2,27%)
Dernière mise à jour : 18:30:02
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Adial Pharmaceuticals Inc ADIL NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,04 2,27% 1,80 18:30:02
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,79 1,7634 1,92 1,76
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
22/4/202414:30GLOBEAdial Pharmaceuticals Granted Key Patent from the United..
10/4/202414:30GLOBEAdial Pharmaceuticals Announces Peer-Reviewed Publication..
02/4/202414:30GLOBEAdial Pharmaceuticals Reports 2023 Fiscal Year Financial..
02/3/202401:00GLOBEAdial Pharmaceuticals Announces Exercise of Warrants for..
28/2/202415:30GLOBEAdial Pharmaceuticals Awarded New Patent from the United..
14/2/202421:22EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202415:15GLOBEAdial Pharmaceuticals Awarded New Patent Notice of Allowance..
25/1/202422:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
25/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
18/1/202422:15EDGAR2Form 8-K - Current report
18/1/202414:30GLOBEAdial Announces Appointment of Tony Goodman as Chief..
16/1/202422:17EDGAR2Form 8-K - Current report
12/1/202422:51EDGAR2Form S-3 - Registration statement under Securities Act of..
20/12/202315:00GLOBEAdial Pharmaceuticals Receives Final Reimbursement Payment..
12/12/202322:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/12/202317:08EDGAR2Form DEF 14A - Other definitive proxy statements
29/11/202322:47EDGAR2Form 8-K - Current report
29/11/202322:05GLOBEAdial Pharmaceuticals Regains Compliance with Nasdaq Listing..
28/11/202322:10EDGAR2Form 8-K - Current report
24/11/202315:24EDGAR2Form PRE 14A - Other preliminary proxy statements
20/11/202313:46EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/11/202323:02GLOBEAdial Pharmaceuticals Reports Third Quarter 2023 Financial..
08/11/202322:05EDGAR2Form S-1 - General form for registration of securities under..
06/11/202312:14EDGAR2Form 8-K - Current report
31/10/202313:30GLOBEAdial Pharmaceuticals Chief Medical Officer and Key Opinion..
30/10/202322:24EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
30/10/202322:18EDGAR2Form 8-K/A - Current report: [Amend]
30/10/202322:17EDGAR2Form NT 10-Q/A - Notification of inability to timely file..
25/10/202314:00GLOBEAddiction Experts Highlight the Need for..
24/10/202322:48EDGAR2Form 8-K - Current report
24/10/202322:30GLOBEAdial Pharmaceuticals Announces Closing of $4 Million..
20/10/202314:00GLOBEAdial Pharmaceuticals Announces $4 Million Private Placement..
19/10/202316:30GLOBEAdial Pharmaceuticals Awarded Notice of Allowance for Key..
18/10/202314:00GLOBEAdial Pharmaceuticals Wins Frost & Sullivan's 2023 North..
03/10/202314:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202313:00GLOBEAdial Pharmaceuticals to Host a Virtual Key Opinion Leader..
27/9/202303:08EDGAR2Form 8-K - Current report
21/9/202322:10EDGAR2Form 8-K - Current report
11/9/202312:03EDGAR2Form 8-K - Current report
05/9/202314:30GLOBEAdial Pharmaceuticals to Present at the H.C. Wainwright 25th..
28/8/202314:30GLOBEAdial Pharmaceuticals Chief Medical Officer and Key Opinion..
23/8/202314:45EDGAR2Form 8-K - Current report
23/8/202314:30GLOBEAdial Pharmaceuticals Regains Compliance with Nasdaq Listing..
21/8/202314:46EDGAR2Form 8-K - Current report
21/8/202314:30GLOBEAdial Pharmaceuticals Reports Second Quarter 2023 Financial..
21/8/202314:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
18/8/202323:05EDGAR2Form 8-K - Current report
15/8/202312:01EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
04/8/202314:30EDGAR2Form 8-K - Current report
04/8/202314:30GLOBEAdial Pharmaceuticals Announces Reverse Stock Split to..

Dernières Valeurs Consultées

NASDAQ
ADIL
Adial Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés